This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 J Danesh , JG Wheeler , GM Hirschfield , S Eda , G Eiriksdottir , A Rumley , GDO Lowe , MB Pepys & V Gudnason (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387–1397.
2 MP de Maat & A Trion (2004) C-reactive protein as a risk factor versus risk marker. Curr Opin Lipidol 15, 651–657.
3 MB Pepys , GM Hirschfield , GA Tennent , (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217–1221.
4 KK Ray , CP Cannon , R Cairns , (2005) Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46, 1417–1424.
5 KJ Joshipura , FB Hu , JE Manson , (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 134, 1106–1114.
6 HC Hung , KJ Joshipura , R Jiang , (2004) Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96, 1577–1584.
7 B Voetsch , RC Jin & J Loscalzo (2004) Nitric oxide insufficiency and atherothrombosis. Histochem Cell Biol 122, 353–367.
12Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23–33.
13 NR Cook , CM Albert , JM Gaziano , E Zaharris , J MacFadyen , E Danielson , JE Buring & JE Manson (2007) A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 167, 1610–1618.
15 BG Brown , XQ Zhao , A Chait , (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345, 1583–1592.
17 U Justesen , P Knuthsen & T Leth (1997) Determination of plant polyphenols in Danish foodstuffs by HPLC–UV and LC–MS detection. Cancer Lett 114, 165–167.
18 C Dalgård , L Christiansen , T Jonung , MI Mackness , MPM de Maat & M Hørder (2007) No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease. Eur J Nutr 46, 354–363.
19 B Frei & MG Trabe (2001) The new US Dietary Reference Intakes for vitamins C and E. Redox Rep 6, 5–9.
22 M Levine , Y Wang , SJ Padayatty & J Morrow (2001) A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A 98, 9842–9846.
23 KT Khaw , S Bingham , A Welch , R Luben , N Wareham , S Oakes & N Day (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 357, 657–663.
24 A Tjonneland , K Overvad , J Haraldsdottir , S Bang , M Ewertz & OM Jensen (1991) Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 20, 906–912.
25 MP de Maat , EM Bladbjerg , T Drivsholm , K Borch-Johnsen , L Moller & J Jespersen (2003) Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost 1, 950–957.
28 J Lykkesfeldt , S Loft & HE Poulsen (1995) Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection – are they reliable biomarkers of oxidative stress? Anal Biochem 229, 329–335.
30 S Mehta & JA Farmer (2007) Obesity and inflammation: a new look at an old problem. Curr Atheroscler Rep 9, 134–138.
31 AM Wilson , JD Swan , H Ding , (2007) Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis 191, 175–181.
32 PM Ridker , CP Cannon , D Morrow , N Rifai , LM Rose , CH McCabe , MA Pfeffer & E Braunwald (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352, 20–28.
33 MPJ de Winther , E Kanters , G Kraal & MH Hofker (2005) Nuclear factor κB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25, 904–914.
35 K Esposito , F Nappo , R Marfella , G Giugliano , F Giugliano , M Ciotola , L Quagliaro , A Ceriello & D Giugliano (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067–2072.
36 M Yano , G Hasegawa , M Ishii , M Yamasaki , M Fukui , N Nakamura & T Yoshikawa (2004) Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep 9, 111–116.
38 VM Breinholt , SE Nielsen , P Knuthsen , ST Lauridsen , B Daneshvar & A Sorensen (2003) Effects of commonly consumed fruit juices and carbohydrates on redox status and anticancer biomarkers in female rats. Nutr Cancer 45, 46–52.
41 B Weinhold & U Rüther (1997) Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 327, 425–429.
42 JV Castell , T Geiger , V Gross , T Andus , E Walter , T Hirano , T Kishimoto & PC Heinrich (1988) Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem 177, 357–361.
43 Z Dibbs , J Thornby , BG White & DL Mann (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33, 1935–1942.
44 S Rose-John , J Scheller , G Elson & SA Jones (2006) Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80, 227–236.
46 A Azzi , R Gysin , P Kempna , A Munteanu , L Villacorta , T Visarius & JM Zingg (2004) Regulation of gene expression by alpha-tocopherol. Biol Chem 385, 585–591.
47 EA Bermudez & PM Ridker (2002) C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease. Prev Cardiol 5, 42–46.
48 U Landmesser , F Bahlmann , M Mueller , (2005) Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 111, 2356–2363.
49 RS Rosenson (2004) Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 173, 1–12.
50 R De Caterina , F Cipollone , FP Filardo , (2002) Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation 106, 2543–2549.
51 W Palmas , S Ma , B Psaty , J Goff , C Darwin & RG Barr (2007) Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. Am J Hypertens 20, 233–241.